ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Remifentanil inhibits the inflammatory response of BV2 microglia and protects PC12 cells from damage caused by microglia activation

Huang, Yankui; Cai, Qingxiang; Liu, Huihui; Wang, Yong; Ma, Wuhua*广州中医药大学; 1
Bioengineered2022-5-2DOI: 10.1080/21655979.2022.2080421
1被引7阅读
引用收藏
分享

摘要

Microglia acts as a critical player in neuroinflammation and neuronal injury. Remifentanil (Rem) has been reported to exert anti-inflammatory activity in several types of diseases. However, the role of Rem in microglia-mediated neuroinflammation is unclear. The present study was designed to investigate the effects of Rem against lipopolysaccharide (LPS)-activated BV2 microglial and PC12 cell induced by activated BV2 microglia. Cell proliferative ability was assessed with cell counting kit-8 assay and cellular morphology was observed. ELISA assay was used to measure the expressions of PGE2 and inflammatory factors. The contents of p-NF-KB p65, p-IKK alpha/beta, and COX2 were evaluated with the aid of western blot. The levels of NO and iNOS were assessed with Griess assay, qRT-PCR, and western blot. In addition, Tunel assay and western blot were performed to assess cell apoptosis. The data revealed that Rem alleviated BV2 microglial morphological injury induced by LPS. Furthermore, Rem suppressed inflammatory releases, iNOS, NO and PGE2 stimulated by LPS in activated BV2 cells. Moreover, Rem suppressed PC12 cell injury, the generations of inflammatory factors and cell apoptosis triggered by inflammatory mediators secreted from activated BV2 cells. These results suggest that Rem exhibited anti-neuroinflammatory activity in protecting PC12 cells against injury derived from LPS-stimulated BV2 microglia.

学科与关键词

关键词
NeuroinflammationRemifentanilBV2 microgliaPC12 cellslipopolysaccharide
相关
加载中…
  • Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation
    Bi Wei; Zhu Lihong; Wang Chuanming; Liang Yanran; Liu Jun; Shi Qiaoyun; Tao Enxiang*Brain Research, 2011, 1395: 12-20.被引 28
  • Cyclooxygenase-2 Inhibitor Parecoxib Reduces LPS-Induced Activation of BV2 Microglia Cells
    Li, X.*; Zhou, J. X.; Qu, Y. D.; Kuang, X.Bulletin of Experimental Biology and Medicine, 2022, 174(2): 210-215.被引 1
  • Roflupram, a novel phosphodiesterase 4 inhibitor, inhibits lipopolysaccharide-induced neuroinflammatory responses through activation of the AMPK/Sirt1 pathway
    Li, Dan; Xu, Jiangping*; Qin, Yunyun; Cai, Ningbo; Cheng, Yufang; Wang, HaitaoInternational Immunopharmacology, 2021, 90: 107176.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioengineered
发表日期
2022-05-02
卷期
第 13 卷, 第 5 期
页码
13944-13955
DOI
10.1080/21655979.2022.2080421
语言
ENGLISH
期刊等级
4区
成果收录
SCIE

作者

  • H

    Huang, Yankui (第一作者)

    1 · guangzhou univ chinese med

  • C

    Cai, Qingxiang

    1 · guangzhou univ chinese med

查看全部 5 位作者收起作者
  • L

    Liu, Huihui

    1 · guangzhou univ chinese med

  • W

    Wang, Yong

    1 · guangzhou univ chinese med

  • M

    Ma, Wuhua (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417